Login
$OGN
$13.90 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Joseph Morrissey
Chief Executive Officer
Title from the Form 8-K dated Apr 26, 2026
Not stated Not stated $5,772,848
Matthew Walsh
Executive Vice President and Chief Financial Officer
59 Since 2021
5 years
$5,686,204
Carrie S. Cox Also a director
Executive Chair
Title from the Form 8-K dated Apr 26, 2026
68 Not stated Not reported
Juan Camilo Arjona Ferreira
Head of R&D & CMO
Title from the Form 4 dated Nov 7, 2026
Not stated Not stated $3,822,487
Aaron Falcione
Chief Human Resources Officer
Title from the Form 4 dated Mar 31, 2026
Not stated Not stated Not reported
Daniel Karp
Executive Vice President, Corporate Development & Chief Strategy Officer
48 Since 2024
2 years
Not reported
Rachel Stahler
Executive Vice President and Chief Digital & Growth Officer
50 Since 2021
5 years
$3,551,619
Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
53 Since 2023
3 years
$3,542,975
Lynette Holzbaur
SVP and Corporate Controller
Title from the Form 4 dated Nov 5, 2026
Not stated Not stated Not reported
Juliana Drinane
Head of Mfg & Supply
Title from the Form 4 dated Nov 7, 2026
55 Not stated Not reported
Vittorio Nisita
Head of Global Business Svcs
Title from the Form 4 dated Mar 31, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
10 of 11
stated in the proxy
Average tenure
4.6 years
from year joined
CEO also chairs the board
No
Carrie S. Cox
Director Age On board Independent Committees Other public boards 2025 pay Source
Carrie S. Cox
68 2021
5 years
Not independent None stated Solventum Corporation, Texas Instruments Inc. $460,645
Robert Essner
78 2021
5 years
Independent
ESG · Chair
None stated $384,140
Alan Ezekowitz, M.D., Ph.D.
72 2021
5 years
Independent
Audit
Septerna, Inc., Fulcrum Therapeutics, Inc. $370,000
Helene Gayle, M.D., M.P.H.
70 2021
5 years
Independent
Talent · Chair
None stated $363,656
Rochelle B. Lazarus
78 2021
5 years
Independent None stated Rockefeller Capital Management, Blackstone, Inc. Not stated
Deborah Leone
61 2021
5 years
Independent
Audit
Corebridge Financial Inc. $370,000
Philip Ozuah, M.D., Ph.D.
63 2021
5 years
Independent
Talent
The Cigna Group $380,000
Cynthia M. Patton
64 2021
5 years
Independent
Audit
None stated $370,000
Ramona Sequeira
60 2025
1 year
Independent
Talent
Novo Nordisk A/S, Edwards Lifesciences Corporation $280,000
Shalini Sharp
51 2021
5 years
Independent
Audit · Chair
BeOne Medicines (previously BeiGene, Ltd.), Septerna, Inc., Neurocrine Biosciences, Inc. $385,000
Grace Puma Leaving at the meeting
Not stated Not stated Independent None stated None stated $360,000

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support